Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.strides.com | |
Market Cap | 2,685.60 Cr. | |
Enterprise Value(EV) | 5,471.83 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -18.15 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 30.86 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 264.10 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.13 | Calculated using Price: 297.40 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 9.03 Cr. | 90,302,704 Shares |
FaceValue | 10 | |
Company Profile | ||
The company's core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers. |
1 Day |
|
+0.55% |
1 Week |
|
-0.33% |
1 Month |
|
-14.86% |
3 Month |
|
-4.91% |
6 Month |
|
-11.88% |
1 Year |
|
-23.92% |
2 Year |
|
-64.64% |
5 Year |
|
-59.38% |
10 Year |
|
-68.56% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 3.36 | 0.09 | 5.25 | 16.53 | 27.00 | 14.74 | 5.83 | 12.91 | -14.17 | |
Return on Capital Employed (%) | 7.76 | 10.92 | 7.54 | 10.75 | 16.07 | 8.65 | 6.13 | 11.17 | -7.28 | |
Return on Assets (%) | 1.48 | 0.04 | 2.03 | 5.79 | 9.59 | 5.22 | 2.19 | 5.35 | -5.35 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 1,007 | 1,145 | 2,658 | 2,749 | 2,464 | 2,649 | 2,527 | 2,777 | 2,359 | 2,331 | |
Non Curr. Liab. | 306 | 286 | 2,760 | 2,049 | 2,067 | 2,343 | 814 | 1,264 | 966 | 978 | |
Curr. Liab. | 707 | 1,020 | 1,892 | 3,104 | 1,899 | 2,662 | 2,545 | 2,738 | 3,412 | 3,305 | |
Minority Int. | 76 | 19 | 50 | 134 | 155 | 153 | 67 | 37 | 24 | -30 | |
Equity & Liab. | 2,096 | 2,469 | 7,360 | 8,035 | 6,585 | 7,807 | 5,953 | 6,817 | 6,761 | 6,585 | |
Non Curr. Assets | 788 | 1,040 | 3,845 | 4,243 | 4,101 | 4,758 | 3,581 | 4,000 | 3,399 | 3,331 | |
Curr. Assets | 1,309 | 1,429 | 3,515 | 3,792 | 2,484 | 3,049 | 2,372 | 2,817 | 3,362 | 3,254 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2,096 | 2,469 | 7,360 | 8,035 | 6,585 | 7,807 | 5,953 | 6,817 | 6,761 | 6,585 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 1,341 | 1,196 | 2,862 | 3,826 | 3,344 | 3,108 | 2,752 | 3,316 | 3,070 | 3,568 | |
Other Income | 60 | 39 | 102 | 398 | 921 | 323 | 53 | 59 | 132 | 172 | |
Total Income | 1,401 | 1,234 | 2,965 | 4,224 | 4,265 | 3,431 | 2,805 | 3,375 | 3,202 | 3,740 | |
Total Expenditure | -1,118 | -967 | -2,482 | -3,309 | -3,109 | -2,812 | -2,236 | -2,689 | -3,090 | -3,274 | |
PBIDT | 284 | 267 | 483 | 915 | 1,156 | 620 | 569 | 686 | 112 | 466 | |
Interest | -109 | -47 | -168 | -183 | -196 | -79 | -156 | -150 | -177 | -230 | |
Depreciation | -56 | -64 | -131 | -199 | -194 | -172 | -174 | -206 | -233 | -243 | |
Taxation | -41 | -148 | -42 | -51 | -21 | -14 | -11 | -32 | 178 | 194 | |
Exceptional Items | -27 | -7 | -41 | -36 | -44 | 22 | -78 | 43 | -244 | -87 | |
PAT | 51 | 1 | 100 | 446 | 701 | 376 | 151 | 342 | -363 | 100 | |
Minority Interest | 1 | 14 | -46 | -20 | -5 | 6 | 11 | 14 | 6 | ||
Share Associate | -5 | 0 | -17 | -46 | -107 | -98 | -111 | -288 | |||
Other Related Items | |||||||||||
Consolidated Net Profit | 1,767 | 845 | 109 | 400 | 665 | 325 | 36 | 268 | -460 | -164 | |
Adjusted EPS | 9 | 0 | 12 | 45 | 74 | 36 | 4 | 30 | -51 | -18 |
Particulars | 10 years | 2012-12 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 134 | -272 | 83 | 73 | 288 | 187 | 60 | 205 | 481 | -258 | |
Cash Fr. Inv. | 807 | 4,077 | 52 | -2,225 | -687 | 583 | -148 | 1,306 | -521 | -119 | |
Cash Fr. Finan. | -990 | -3,319 | -421 | 2,944 | 338 | -1,016 | 194 | -1,709 | -16 | 421 | |
Net Change | -49 | 487 | -286 | 792 | -60 | -246 | 106 | -199 | -55 | 45 | |
Cash & Cash Eqvt | 132 | 586 | 298 | 1,111 | 515 | 256 | 366 | 182 | 126 | 171 |
Tue, 07 Feb 2023
Shareholders meeting
|
|
Tue, 07 Feb 2023
Shareholders meeting
|
|
Thu, 02 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
Wed, 08 Feb 2023 |
|
|
|
Tue, 07 Feb 2023 |
|
|